PDF(Pubmed)
Abstract：
HPV is the most prevalent sexually transmitted infection in the U.S., with more than 80% of all Americans contracting it by age 45. Effective vaccines for HPV exist and were recently approved for adults aged 27-45 years, though uptake remains low in all age groups, particularly in Tennessee where 1089 cancers were attributed to HPV in 2020. Between 29 June and 17 August 2023, we conducted a cross-sectional survey to gain insights about the barriers and facilitators of HPV in 2011 adults aged 18 to 45 years in Tennessee. We developed our survey based on previous instruments to understand predictors of HPV vaccination in adults. Using descriptive statistics and bivariate and logistic regression analyses, we found higher vaccination rates in females, participants aged 18-38 years, participants with a high school education or higher, Hispanic or Latine individuals, and participants identifying as moderate or liberal. These insights highlight the need for public health interventions that consider demographic differences to successfully increase vaccination rates and reduce HPV-associated cancer risk.
摘要：
HPV是美国最普遍的性传播感染，超过80%的美国人在45岁时感染了这种疾病。存在有效的HPV疫苗，并且最近被批准用于27-45岁的成年人。尽管所有年龄组的摄入量仍然很低，特别是在田纳西州，在2020年，1089种癌症归因于HPV。在2023年6月29日至8月17日之间，我们进行了一项横断面调查，以了解田纳西州2011年18至45岁成年人的HPV障碍和促进因素。我们基于以前的工具开发了我们的调查，以了解成人HPV疫苗接种的预测因素。使用描述性统计、双变量和逻辑回归分析，我们发现女性的疫苗接种率更高，18-38岁的参与者，具有高中或更高学历的参与者，西班牙裔或拉丁裔人，和参与者确定为温和或自由。这些见解强调需要考虑人口统计学差异的公共卫生干预措施，以成功提高疫苗接种率并降低与HPV相关的癌症风险。
